Devendra K Hiwase

27PUBLICATIONS
176CO-AUTHORS
Medical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Gene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 01, 2026
Infection risk in myelodysplastic syndromes is dynamic and immune driven.

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|May 13, 2025
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

Julie A I Thoms, Feng Yan, Henry R Hampton

|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

Pageof 5

Frequent Collaborators

15 joint publications

Mithun Vinod Shah

9 joint publications

Chung Hoow Kok

9 joint publications

Naseema Gangat

9 joint publications

Mrinal Patnaik